Miromatrix Medical (MIRO) IPO Opens 33% Higher

Today's IPO for Miromatrix Medical Inc. (Nasdaq: MIRO) opened for trading at $12 after pricing 4,800,000 shares of common stock at a price to the public of $9.00 per share.

The offering is being made through Craig-Hallum Capital Group, which is acting as sole managing underwriter for the offering.

Miromatrix Medical Inc. (Nasdaq: MIRO) is a life sciences company pioneering a novel technology for bioengineering fully transplantable human organs to help save and improve patients' lives. The Company has developed a proprietary perfusion technology platform for bioengineering organs that it believes will efficiently scale to address the shortage of available human organs. The Company's initial development focus is on human livers and kidneys.

You May Also Be Interested In

• Iambic Therapeutics prices IPO at $16 per share on Nasdaq
• TUSK Practice Sales Releases Q4 2026 Dental Market Report on DSO Expansion, Tighter Financing and Exit Planning
• Increasing unusual option volume: CMPX UTHR AIPO BSP UNIT CRVS UMC